Search
Indantadol
go.drugbank.com/drugs/DB12664InvestigationalIndantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesMethylselenocysteine
go.drugbank.com/drugs/DB12697InvestigationalMethylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.
Categories: Compounds used in a research, industrial, or household settingIndium In-111 satumomab pendetide
go.drugbank.com/drugs/DB00057ApprovedWithdrawnTumor associated glycoprotein (TAG) 72 (B72.3) monoclonal antibody conjugated with Indium 111 for radioimaging colon tumors. Satumomab Pendetide (trade name: OncoScint®) is no longer commercially available.
Muromonab
go.drugbank.com/drugs/DB00075ApprovedInvestigationalWithdrawnMore specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method.
Technetium Tc-99m arcitumomab
go.drugbank.com/drugs/DB00113ExperimentalThe molecule has a molecular weight of ~54,000 Daltons.
Capreomycin
go.drugbank.com/drugs/DB00314ApprovedInvestigationalCyclic peptide antibiotic similar to viomycin. It is produced by Streptomyces capreolus.
Categories: Drugs that are Mainly Renally Excreted with a Narrow Therapeutic IndexKava
go.drugbank.com/drugs/DB01322ApprovedInvestigationalNutraceuticalWithdrawnCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates17alpha-methyl-4-hydroxynandrolone
go.drugbank.com/drugs/DB01540ExperimentalIllicit17alpha-methyl-4-hydroxynandrolone is a schedule 3 anabolic steroid.
Methyl-1-testosterone
go.drugbank.com/drugs/DB01572ExperimentalIllicitIt is a derivative of 1-testosterone with a methyl group in the carbon 17. Methyl-1-testosterone is considered a prohibited doping substance. … Methyl-1-testosterone is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use.
AZD-9684
go.drugbank.com/drugs/DB05712ExperimentalAZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.